Total Share Holders Equity (after Deducting Minority Equity)
130,017,502
102,861,943
26.4
Profit (Loss) per Share
3.85
3.69
All figures are in (Actual) Saudi Arabia, Riyals
Element List
Explanation
The reason of the increase (decrease) in the net profit during the current year compared to the last year is
The reasons for the increase in annual profits for the year 2022 compared to the year 2021 is represented in the increase in the number of patients by an estimated rate of 21% compared to last year, and this increase also led to an increase in the revenues of ancillary services, which are represented in laboratory, x-ray and pharmacy services, by an estimated rate of 19%.
Statement of the type of external auditor's report
Unmodified opinion
Modification, Qualification or Emphasis of a Matter as Stated within the External Auditor Opinion
Not Exist
Reclassification of Comparison Items
Comparative figures have been reclassified to conform to the current year's presentation
Accounting programs have been modified with a value of 200 thousand riyals from property and equipment to intangible assets, which were completely depreciated in the past
The long-term loans have been modified at a value of 8 million riyals to become long-term loans in the current part, and the reclassification does not affect the previously announced profit for the year ending on December 31, 2021, in the comprehensive and previously disclosed cash flow statement from investing and financing activities in the statement of cash flows for the year ended with that date
Additional Information
The basic and diluted share capital is calculated by dividing the profit for the year attributable to the company's shareholders by the weighted average number of ordinary shares issued during the year.
Since the company does not have any potentially dilutive shares, the diluted share life is the same as the basic share life.
Attached Documents
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.